CVE-2024-34398 Cross-site scripting in n/a
Authenticated attackers can inject stored HTML into BMC Remedy Mid Tier, potentially leading to session hijacking or malicious script execution.
- Exploited in the wild
- Not known
- Login needed
- Any signed-in user
- Attackable
- Over the internet
- Victim action needed
- Not needed
- Fix
- None listed
What is CVE-2024-34398?
CVE-2024-34398 is a medium-severity cross-site scripting vulnerability in n/a, published on 12 Mar 2025. Any signed-in user can exploit it over the network, with no action from the victim.
Official description
An issue was discovered in BMC Remedy Mid Tier 7.6.04. The web application allows stored HTML Injection by authenticated remote attackers.
Weakness: CWE-80
Which versions are affected by CVE-2024-34398?
It affects 1 product.
Products include Bmc Remedy Mid-Tier.
How do I fix CVE-2024-34398?
No fix has been published for CVE-2024-34398 yet. Limit exposure of the affected software until one is available.
Escape output for the context it lands in and set a strict Content Security Policy. Upgrading the affected component is the real fix. More about Cross-site scripting.
Is CVE-2024-34398 being exploited?
There is no known exploitation of CVE-2024-34398 in the wild and no public exploit code.
Other vulnerabilities in n/a
Sources
Also known as GHSA-j3vw-gxh2-3r2w.